|
Age (years)
|
72 (43–91)
|
74 (64–82)
|
72 (51–79)
|
0.14
|
|
Sex (male/female)
|
80/39
|
10/1
|
16/4
|
0.16
|
|
HBsAg positive (%)
|
12 (10)
|
2 (18)
|
5 (25)
|
0.15
|
|
HCVAb positive (%)
|
76 (64)
|
1 (9)
|
7 (35)
|
0
|
|
AST (IU/l)
|
53 (14–240)
|
56 (17–238)
|
113 (13–384)
|
<0.0001
|
|
ALT (IU/l)
|
39 (10–202)
|
53 (14–190)
|
78 (8–157)
|
0.02
|
|
Total serum bilirubin (mg/dl)
|
0.8 (0.3-3.1)
|
0.7 (0.3-6.1)
|
1.6 (0.3-8.3)
|
0
|
|
Albumin (g/dl)
|
3.7 (2.1-5)
|
3.9 (3.5-4.6)
|
3.2 (2.2-3.4)
|
<0.0001
|
|
CRP (mg/dl)
|
0.1 (0.1-0.9)
|
1.5 (1.1-2.9)
|
2.6 (1.1-18.8)
|
<0.0001
|
|
WBC (cells/mm3 )
|
5200 (1800–14900)
|
5900 (3500–10600)
|
5800 (3900–12400)
|
0.07
|
|
Platelet count (104/mm3 )
|
13.2 (2.8-30.9)
|
25.3 (1.8-42.1)
|
17.3 (8.7-44.3)
|
0
|
|
Prothrombin time (%)
|
83 (38–100)
|
95 (74–100)
|
77 (45–97)
|
0.01
|
|
α-fetoprotein (ng/ml)
|
22 (1.9-59597)
|
77 (2–138011)
|
144 (1.7-280600)
|
0.05
|
|
Child-Pugh grade (A/B/C)
|
91/26/2
|
10/1/0
|
6/10/4
|
<0.0001
|
| CLIP score (0/1/2/3≧) |
41/43/24/11
|
3/0/3/5
|
0/7/1/12
|
<0.0001
|
| JIS score (0/1/2/3≧) |
18/43/41/17
|
0/4/3/4
|
0/1/6/13
|
<0.0001
|
|
BCLC score (0/A/B/C,D)
|
18/61/31/9
|
0/4/2/5
|
0/6/2/12
|
<0.0001
|
|
Tumor stage (І,ІІ,ІІІ,ІV)
|
21/52/41/5
|
0/4/3/4
|
1/4/4/11
|
<0.0001
|
|
Maximal tumor diameter (mm)
|
30 (7–200)
|
110 (40–150)
|
50 (10–130)
|
<0.0001
|
|
Tumor number (solitary/multiple)
|
66/53
|
6/5
|
5/15
|
0.04
|
|
Vascular invasion (absent/present)
|
114/5
|
8/3
|
13/7
|
<0.0001
|
|
Extrahepatic metastasis (absent/present)
|
117/2
|
10/1
|
17/3
|
0.01
|
